Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxysafflor Yellow A Injection vs Dengzhan Xixin Injection in Acute Atherosclerotic Thrombotic Cerebral Infarction
CTR20130222Phase 2Completed
- Sponsor
- Tiansanqi
- Start
- Jan 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxysafflower yellow a in brain infarction, ischemic stroke, sponsored by Tiansanqi. Started Jan 2014; status: completed.
02
Drugs
hydroxysafflower yellow a
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on CTR20130222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130222.